Docetaxel in combined-modality treatment of inoperable locally or regionally advanced lung cancer

Lung Cancer

Volumn 46, Issue SUPPL. 2, 2004, Pages

  Scagliotti, Giorgio V ^a   Douillard, J Y ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b CENTRE RENÉ GAUDUCHEAU   (France)

Author keywords

Combined modality therapy; Docetaxel; Multimodality therapy; Non small cell lung cancer; Taxane

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEFITINIB; GEMCITABINE; IRINOTECAN; MITOMYCIN C; NAVELBINE; PACLITAXEL; PLATINUM DERIVATIVE; VINBLASTINE; VINDESINE;

ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHENIA; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DIARRHEA; DYSPNEA; ESOPHAGITIS; FEBRILE NEUTROPENIA; HUMAN; INFECTION; LEUKOPENIA; LIVER DYSFUNCTION; LUNG NON SMALL CELL CANCER; LYMPHOCYTOPENIA; METASTASIS; NEUTROPENIA; NONHUMAN; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; TAXOIDS;

EID: 13244272254     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(04)80037-0     Document Type: Article

References (37)

1. Mountain C.F. Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
2. Ihde D.C. Chemotherapy combined with chest irradiation for locally advanced non-small cell lung cancer Ann Intern Med 115 1991 137 739
3. Robinson L.A., Wagner H., and Ruckdeschel J.C. Treatment of stage IIIA non-small cell lung cancer Chest 123 2003 102S 220S
4. Arriagada R., Lechevalier T., and Quoix E. GETCB CEBI and FNLCC trialists Effect of chemotherapy on locally advanced non small cell carcinoma: a randomized study on 353 patients Int J Radiat Oncol Biol Phys 20 1991 1183 1190
5. Dillman R.O., Seagren S.L., and Propert K.J. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 1990 140 945
6. Marino P., Preatoni A., and Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapyin stages IIIa and IIIb non-small cell lung cancer Cancer 76 1995 193 601
7. Pritchard R.S., and Anthony S.P. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer Ann Intern Med 125 1996 123 729
8. accessed Gandara D.R., Green M.R., Lara P.N., and Meyer M.L. Treatment strategies for advanced non-small cell lung cancer 1Medscape, 2003 Nov 11, 2003
9. Furuse K., Fukuoka M., and Kawahara M. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stageIII non-small-cell lung cancer J Clin Oncol 17 1999 1692 2699
10. Abstract and presentation 1891 Curran W., Scott C., and Langer C. Phase III comparison of sequential vs concurrent chemoradiation for patients (pts) with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410 Proc Am Soc Clin Oncol 18 2000
11. Abstract 2499 Curran W.J., Scott C.B., and Langer C.J. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410 Proc Am Soc Clin Oncol 22 2003 121
12. Abstract 1246 Fournel P., Perol M., and Gilles R. A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemoradiotherapy in locally advanced non small cell lung cancer (NSCLC) (GLOT-GFPC NPC 95-01 study) Proc Am Soc Clin Oncol 2001
13. (suppl) Kim E.S., and Khuri F.R. Docetaxel and radiation as combined-modality therapy Oncology 16 2002 97 105
14. Mason K.A., Kishi K., and Hunter N. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo Clin Cancer Res 5 1999 1191 4198
15. Abstract 327 Aamdadl S., Lauvvang G., and Owre K. A phase I/II study of docetaxel (Taxotere) combined with concurrent radiation therapy in locally advanced non-small cell lung cancer (NSCLC) Lung Cancer 29 2000 100
16. Koukourakis M.I., Kourousis C., and Kamilaki M. Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial Eur J Cancer 34 1998 138 844
17. Koukourakis M.I., Bahlitzanakis N., and Froudarakis M. Concurrent conventionally fractionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-smallcell lung carcinoma Br J Cancer 80 1999 1792 1796
18. Abstract 2014 Sistermanns J., and Hoffmanns H. Phase II study of docetaxel with simultaneous radiochemotherapy in patients with locally advanced non-resectable non-small cell lung cancer (NSCLC) Proc Am Soc Clin Oncol 18 1999 122a
19. Abstract 1271 Vergnenegre A., Daniel C., and Lena H. A phase II of induction chemotherapy (platin-vinorelbine, P-V) followed by weekly docetaxel (D) with concurrent chest radiation (RT) in locallyadvanced NSCLC (GFPC* (*) 2000-01 study) Proc Am Soc Clin Oncol 21 2002 118a
20. Mudad R., Ramsey M., and Kovitz K. Concomitant weekly docetaxel, cisplatin and radiation therapy in the treatment of locallyadvanced non-small cell lung cancer: a dose-finding study Lung Cancer 39 2003 173 177
21. Abstract 1988 Segawa Y., Ueoka H., and Kiura K. A phase I/ll study of docetaxel (TXT) and cisplatin (CDDP) with concurrent thoracic radiotherapy (TRT) for locally advanced non-small-cell lungcancer (LA-NSCLC) Proc Am Soc Clin Oncol 19 2000 108a
22. Abstract 2766 Yamamoto N., Nakagawa K., and Uezima H. Phase I study of weekly chemotherapy of docetaxel (DOC) + cisplatin (CDDP) with concurrent throacic radiation therapy (TRT) for unresectable stage III non-small cell lung cancer (NSCLC): correlation between A1-acid-glycoprotein (AAG) and esophagitis Proc Am Soc Clin Oncol 20 2001 154b
23. Wu H.-G., Bang Y.-J., and Choi E.K. Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non-small-cell lung cancer Int J Radiation Oncology Biol Phys 52 2002 15 80
24. Choy H., DeVore R.F., and Hande K.R. Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial Lung Cancer 34 2001 141 449
25. Wirth L., Lucca J., and Ostler P. Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer Clin Cancer Res 9 2003 1698 1704
26. Abstract 2105 Kubota K., Matsumoto T., and Kakinuma R. Phase I study of weekly docetaxel (DTX), carboplatin (CBDCA) and concurrent thoracic radiotherapy (TRT) in stage III non-small cell lung cancer(NSCLC) Proc Am Soc Clin Oncol 19 2000 135a
27. Abstract 7174 Suzuki R., Taniguchi H., and Kondoh Y. A phase II trial of concurrent radiochemotherapy with carboplatin (CBDCA) and weekly docetaxel (TXT) in locally advanced non-small cell lung cancer(NSCLC) Proc Am Soc Clin Oncol 13 2004 156
28. Abstract 1279 Scagliotti G.V., Manegold C., and Buchholz E. Randomized phase II study evaluating the feasibility of thoracic radiotherapy with or without weekly docetaxel (Taxotere) following inductionchemotherapy with cisplatin (DDP) and docetaxel in unresectable stage IIIA/B non-small cell lung cancer Proc Am Soc Clin Oncol 21 2002 120a
29. Abstract 491 PD Ramlau R., Scagliotti G.V., and Manegold C. Radiotherapy and concurrent weekly docetaxel following cisplatin-docetaxel chemotherapy in unresectable stage IIIA-B non-small-cell lung cancer: a randomized phase II trial Ann Oncol 13 suppl 5 2002 134
30. Abstract P-601 Manegold C., Ramlau R., and Scagiotti G.V. A phase II randomized study of thoracic radiotherapy with or without weekly docetaxel following docetaxel-cisplatin induction chemotherapy inunresectable stage IIIA-IIIB non-small cell lung cancer Lung Cancer 41 Suppl 2 2003 S243 s2
31. Abstract 7005 Vokes E.E., Herndon J.E., and Kelley M.J. Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small celllung cancer (NSCLC): initial analysis of a randomized phase III trial Proc Am Soc Clin Oncol 13 2004 116
32. Gandara D.R., Chansky K., and Albain K.S. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504 J Clin Oncol 21 2003 1004 2010
33. Albain K.S., Crowley J.J., and Turrisi A.T. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group Phase II study, SWOG 9019 J Clin Oncol 20 2002 1454 3460
34. Fossella F.V. Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials Semin Oncol 26 suppl 16 1999 17 23
35. Fossella F.V., DeVore R., and Kerr R.N. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens J Clin Oncol 18 2000 1354 2362
36. Blagosklonny M., Schulte T.W., and Nguyen P. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway Cancer Res 56 1996 1851 1854
37. Abstract 4879 Gumerlock P.H., Mack P.C., and Manorek G.H. Bcl-2 phosphorylation and p27 induction as potential p53-independent mechanisms of apoptotic response to taxanes in non-small cell lung carcinoma Proc Am Soc Clin Oncol 40 1999 139